MOLECULAR GENETIC TESTING OF ACCP-POSITIVE PATIENTS WITH RHEUMATOID ARTHRITIS AND HIGH INFLAMMATORY DISEASE ACTIVITY (A REMARCA STUDY)
Rheumatoid arthritis (RA) is a multifactorial disease, in which the interaction of the genetic component and environmental factors, determines not only the development of the disease, but also its pronounced clinical polymorphism. We assume that the high inflammatory activity of RA may be determined...
Saved in:
| Main Authors: | I. A. Guseva, E. L. Luchikhina, N. V. Demidova, A. S. Avdeeva, N. E. Soroka, D. D. Abramov, M. V. Cherkasova, E. Yu. Samarkina, D. E. Karateev, E. L. Nasonov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2018-03-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/2496 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INVESTIGATION OF CANDIDATE GENE POLYMORPHISMS IN AN IMMUNE RESPONSE AS MARKERS FOR THE RISK OF DEVELOPING RHEUMATOID ARTHRITIS AND PRODUCING AUTOANTIBODIES
by: I. A. Guseva, et al.
Published: (2016-03-01) -
Anti-carbamylated protein antibodies in ACCP-negative and ACCP-positive patients with rheumatoid arthritis
by: D. A. Dibrov, et al.
Published: (2024-01-01) -
The rs7574865 polymorphism of the <i>STAT4</i> gene and risk of early rheumatoid arthritis development (the REMARKA study)
by: I. A. Guseva, et al.
Published: (2019-03-01) -
ROLE OF MATRIX METALLOPROTEINASE 3 IN PREDICTING THE EFFICIENCY OF THERAPY FOR EARLY RHEUMATOID ARTHRITIS: THE REMARCA TRIAL
by: A. S. Avdeeva, et al.
Published: (2016-03-01) -
Association of genetic markers with the efficiency of tocilizumab treatment for rheumatoid arthritis
by: Irina Anatolyevna Guseva, et al.
Published: (2013-11-01)